FI946189A - 17-Alkyl ketone steroids useful as 5-alpha reductase inhibitors - Google Patents

17-Alkyl ketone steroids useful as 5-alpha reductase inhibitors Download PDF

Info

Publication number
FI946189A
FI946189A FI946189A FI946189A FI946189A FI 946189 A FI946189 A FI 946189A FI 946189 A FI946189 A FI 946189A FI 946189 A FI946189 A FI 946189A FI 946189 A FI946189 A FI 946189A
Authority
FI
Finland
Prior art keywords
reductase inhibitors
alkyl ketone
alpha reductase
steroids useful
ketone steroids
Prior art date
Application number
FI946189A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI946189A0 (en
Inventor
Dennis Alan Holt
Mark Alan Levy
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of FI946189A0 publication Critical patent/FI946189A0/en
Publication of FI946189A publication Critical patent/FI946189A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI946189A 1992-06-30 1994-12-30 17-Alkyl ketone steroids useful as 5-alpha reductase inhibitors FI946189A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929213835A GB9213835D0 (en) 1992-06-30 1992-06-30 Compounds
PCT/US1993/006238 WO1994000125A1 (en) 1992-06-30 1993-06-30 17-ALKYLKETONE STEROIDS USEFUL AS 5-α-REDUCTASE INHIBITORS

Publications (2)

Publication Number Publication Date
FI946189A0 FI946189A0 (en) 1994-12-30
FI946189A true FI946189A (en) 1994-12-30

Family

ID=10717920

Family Applications (1)

Application Number Title Priority Date Filing Date
FI946189A FI946189A (en) 1992-06-30 1994-12-30 17-Alkyl ketone steroids useful as 5-alpha reductase inhibitors

Country Status (23)

Country Link
EP (1) EP0651643A4 (en)
JP (1) JPH08500821A (en)
KR (1) KR950702118A (en)
CN (1) CN1095382A (en)
AP (1) AP412A (en)
AU (1) AU4545993A (en)
BG (1) BG99313A (en)
BR (1) BR9306748A (en)
CA (1) CA2138956A1 (en)
CZ (1) CZ334694A3 (en)
FI (1) FI946189A (en)
GB (1) GB9213835D0 (en)
HU (1) HUT69409A (en)
IL (1) IL106158A0 (en)
MA (1) MA22927A1 (en)
MX (1) MX9303970A (en)
NO (1) NO945074L (en)
OA (1) OA10122A (en)
RU (1) RU94046378A (en)
SI (1) SI9300350A (en)
SK (1) SK159994A3 (en)
WO (1) WO1994000125A1 (en)
ZA (1) ZA934645B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925774A (en) * 1991-01-07 1999-07-20 Pherin Corporation Estrenes for inducing hypothalamic effects
CA2135056A1 (en) * 1992-05-20 1993-11-25 Donald W. Graham New delta-17 and delta-20 olefinic and saturated 17b-substituted-4-aza-5a-andros-tan-3-ones as 5a-reductase inhibitors
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
GB201102913D0 (en) 2011-02-18 2011-04-06 Univ Birmingham Novel therapeutic
JP2015129095A (en) 2013-12-19 2015-07-16 ロレアル composition
WO2019154257A1 (en) * 2018-02-11 2019-08-15 江苏豪森药业集团有限公司 Steroid derivative regulators, method for preparing the same, and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954446A (en) * 1988-05-25 1990-09-04 Smithkline Beecham Corporation Aromatic steroid 5-α-reductase inhibitors

Also Published As

Publication number Publication date
RU94046378A (en) 1996-10-10
NO945074D0 (en) 1994-12-29
EP0651643A1 (en) 1995-05-10
BR9306748A (en) 1998-12-08
FI946189A0 (en) 1994-12-30
CN1095382A (en) 1994-11-23
GB9213835D0 (en) 1992-08-12
HUT69409A (en) 1995-09-28
JPH08500821A (en) 1996-01-30
AP9300542A0 (en) 1993-07-31
AP412A (en) 1995-09-29
SI9300350A (en) 1993-12-31
AU4545993A (en) 1994-01-24
EP0651643A4 (en) 1995-10-04
OA10122A (en) 1996-12-18
SK159994A3 (en) 1996-01-10
BG99313A (en) 1995-09-29
NO945074L (en) 1995-02-16
ZA934645B (en) 1994-01-25
MA22927A1 (en) 1994-04-01
WO1994000125A1 (en) 1994-01-06
IL106158A0 (en) 1993-10-20
CA2138956A1 (en) 1994-01-06
CZ334694A3 (en) 1995-10-18
KR950702118A (en) 1995-06-19
MX9303970A (en) 1994-04-29

Similar Documents

Publication Publication Date Title
DK226888A (en) STEROID 5-ALFA REDUCTASE INHIBITOR
ZA948064B (en) Method of training androgenic alopecia with 5-alpha reductase inhibitors
FI945362A (en) Method for preparation of monocyclopentadienyl metal complex compounds and method of use
DE69320241D1 (en) Chemically amplified resist composition
AU4251993A (en) Substituted 4-aza-5A-androstan-ones as 5A-reductase inhibitors
FI945457A (en) Inhibitors of testosterone 5alpha reductase activity
DE69311821D1 (en) Atomic frequency standard
DE69224982D1 (en) NEW STEROID ESTER
FI925896A (en) RELEASE COMPOSITION FOR RELEASE OF THE FOLLOWING FOR METAL RELEASE
ATE178611T1 (en) NEW STEROIDS
ATE197799T1 (en) STEROID NITRITE AND NITRATE ESTER COMPOUNDS AND THEIR USE AS ANTIPHLOGISTIC DRUGS
ITMI911432A0 (en) STEROIDS 3-CARBOXY 17B - UNSATURATED SUBSTITUTED
AU2112995A (en) Use of estrone derivatives as steroid sulphatase inhibitors
FI946189A (en) 17-Alkyl ketone steroids useful as 5-alpha reductase inhibitors
FI946106A (en) Steroidal glycosides
DE69333328D1 (en) Photopolymerizable compositions
AU2001268661A1 (en) 20-fluoro-17(20)-vinyl steroids as inhibitors of c17-20-lyase and 5-alpha reductase
EP0462665A3 (en) Selected 17beta-polyaroyl-4-aza-5alpha-androst-1-en-3-ones as steroidal reductase inhibitors
ATE70536T1 (en) STEROID 5-ALPHA REDUCTASE INHIBITORS.
IL105527A0 (en) 17-beta-acyl-aromatic steroid 5-alpha-reductase inhibitors
AU718358C (en) Inhibitors of testosterone 5-alpha reductase activity
AU4688197A (en) Inhibitors of testosterone 5-alpha reductase activity
NO891776D0 (en) STEROID 5-ALFA REDUCTASE INHIBITORS.
FI943835A0 (en) Intermediates for use in the preparation of steroid 5-alpha reductase inhibitors
IL107697A0 (en) Agent and method for the immunological determination of amiodarone and its metabolites

Legal Events

Date Code Title Description
FD Application lapsed